SANUWAVE Health, Inc. (SNWV) P/E Ratio History
UndervaluedTrading at 21.0x vs 5Y avg 38.4x · 50th percentile · Below historical baseline · Data 2025–2026
Loading P/E history...
P/E Ratio Analysis
As of June 28, 2026, SANUWAVE Health, Inc. (SNWV) trades at a price-to-earnings ratio of 21.0x, with a stock price of $8.61 and trailing twelve-month earnings per share of $1.87.
The current P/E is 45% below its 5-year average of 38.4x. Over the past five years, SNWV's P/E has ranged from a low of 17.4x to a high of 59.5x, placing the current valuation at the 50th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.0x, SNWV is roughly in line with its sector peers. The sector includes 231 companies with P/E ratios ranging from 0.0x to 191.4x.
Relative to the broader market, SNWV trades roughly in line with the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our SNWV DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
SNWV Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
SNWV P/E vs Peers
Aesthetics, dermatology, and wound care peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $59M | 14.0Lowest | - | +125%Best | |
| $7B | 32.2 | - | -22% | |
| $1B | 23.8 | 0.65Best | -65% | |
| $4B | 33.7 | - | +5% | |
| $25B | 51.6 | 6.24 | +2% | |
| $17B | 30.5 | - | -25% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
SNWV Historical P/E Data (2025–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $17.29 | $0.99 | 17.4x | -55% |
| FY2025 Q4 | Dec 31 2025 | $29.84 | $0.50 | 59.5x | +55% |
Average P/E for displayed period: 38.4x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
1+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SNWV — Frequently Asked Questions
Quick answers to the most common questions about buying SNWV stock.
What is SNWV's P/E ratio?
SANUWAVE Health, Inc. (SNWV) trailing twelve-month P/E ratio is 21.0x, based on TTM diluted EPS of $1.87. The 5-year average P/E is 38.4x and the historical range spans 17.4x to 59.5x.
Is SNWV stock overvalued or undervalued?
SNWV trades at 21.0x P/E, below its 5-year average of 38.4x. At the 50th percentile of its historical range (17.4x–59.5x), the stock is priced at a discount to its own history.
Is SNWV stock expensive?
No, SNWV is not expensive on a historical basis. The current P/E of 21.0x is below the 5-year average of 38.4x and sits at the 50th percentile of its valuation range.
What is SNWV's historical P/E range?
Over the past 5 years, SNWV's P/E ratio has ranged from 17.4x to 59.5x, with a median of 59.5x and an average of 38.4x. The current P/E of 21.0x places the stock at the 50th percentile of this range. Full historical data spans 2025–2026.
How does SNWV's P/E compare to the S&P 500?
SNWV trades at 21.0x P/E versus the S&P 500 median of 25.3x. The 17% discount to the market suggests lower growth expectations or perceived higher risk.
How does SNWV's valuation compare to Healthcare peers?
SANUWAVE Health, Inc. P/E of 21.0x compares to the Healthcare sector median of 23.0x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is SNWV's PEG ratio?
SNWV PEG ratio is N/A, based on a P/E of 21.0x and EPS growth of 105.8%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is SNWV's earnings yield?
SNWV earnings yield is 4.76%, the inverse of its 21.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.